Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Curaleaf Holdings Inc (OP:CURLF)

0.8700 -0.0224 (-2.51%)
Streaming Delayed Price Updated: 10:15 AM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Curaleaf Holdings Inc

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
52 53 Next >
Cannabis Reports Highlight $339M And $297.6M Revenue Insights In Curaleaf And Trulieve's Q1 2024 Financials
A recent Beacon Securities report focuses on Curaleaf's strategic financial management and the potential impacts of legislative changes on its operations. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Undiscovered Stocks to Buy for 3-Bagger Returns by 2025
Undiscovered stocks picks to buy represent undervalued ideas with strong fundamentals and a robust growth outlook. 
Via InvestorPlace
CURLF Stock Earnings: Curaleaf Holdings Misses EPS, Misses Revenue for Q1 2024
CURLF stock results show that Curaleaf Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Curaleaf Reports Q1 2024 Revenue Of $339M, 48% Gross Margin Amid Strategic Global Expansion
Curaleaf Holdings, Inc. (OTC: CURLF), a leading international cannabis company, reported its financial results for the first quarter of 2024. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Curaleaf Reports 16% Reduction In Net Loss In Q1 Financial Report
Curaleaf has evolved from an MSO to an MCO, a multi-country operator, doing business in 15 countries worldwide with the expectation of creating further separation from their peers. 
Via Talk Markets
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
Ignite your portfolio with these seven sizzling cannabis stocks. From industry leaders to innovative upstarts. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Medical Marijuana Giant Trulieve, Backer Of Florida's Recreational Cannabis Ballot, Narrows Loss, Reports Uptick In Q1 Revenue, Gross Profit
Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahassee, Florida-based medical cannabis giant reported revenue of $298 million... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
These top cannabis stocks by revenue are among the world's best sellers, making them prime investment opportunities to capture legal changes. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For May 7, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Retreat On New Rescheduling Order Developments: What's Going On?
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits alongside heroin and LSD, but new reports suggest the proposal has... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Prohibitionist Group Says DEA Announcement on Cannabis Rescheduling Coming “Very Soon”
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: 'Cannabis Is Just Getting Started,' Says This Top Stock Expert Who Knows How To Capitalize On Swing Trades
"Cannabis is just getting started and there's going to be a lot of companies getting ready to take advantage of this massive growth cycle, government reform, news states, opening new opportunities and... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Credit Check: What Does DEA Rescheduling Mean For Cannabis Credit Ratings? Big Companies' Risk-Return Profiles
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations of multi-state operators (MSOs). 
Via Benzinga
Topics Cannabis
Exposures Cannabis
New Tax Rules In Cannabis: What Are The Consequences DEA Rescheduling?
Discover the transformative effects of marijuana rescheduling on the cannabis industry, focusing on tax relief, financial improvements... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Cannabis Stocks That Can Post Gains As US Shifts To Softer Regulations
After a long time, regulatory winds are shifting in favor of marijuana stocks. Could sustained profitability be finally within reach? 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Stock Market Crash Alert: 3 Must-Buy Cannabis Stocks When Prices Plunge
These are the cannabis stocks to buy as they represent attractive companies positioned for stellar growth and EBITDA margin expansion. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and... 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
3 Hot Cannabis Stocks With Multibagger Return Potential Before the Presidential Election
These are the cannabis stocks to buy as they represent companies positioned to grow at a stellar pace coupled with margin expansion 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
420 with CNW — Politicians Tout Cannabis Policy Reform Progress as 4/20 Celebrations Take Place
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
The Top 3 Cannabis Stocks to Buy in April 2024
These cannabis stocks are well-positioned to benefit from growth of the cannabis market and provide investors with great returns in April. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
3 Cannabis Stocks That Could Be Multibaggers in the Making: April Edition
These are the potential multibagger cannabis stocks to buy at undervalued levels, as they represent companies poised for stellar growth. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For April 25, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis (De)Unionization: Here's What's New On The Frontlines Of Labor Organizing Among Weed Workers
Employees at Cresco Labs Inc.'s Fall River, Massachusets-based cannabis cultivation operations have voted overwhelmingly to approve their first union contract with the United Food and Commercial... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Who's Winning In Weed? Analyst Looks At Cannabis Market's Big Players, Where Are The Best Bets?
In the first quarter of 2024, the cannabis sector faces a mixed economic landscape with a notable sequential decline in sales across several states. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Curaleaf Boosts International Presence With Another Cannabis Acquisition
Cannabis giant Curaleaf Holdings is closing its previously announced acquisition of Northern Green Canada, a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Market Flourishes Amid Global Legalization, Driving Concerns About Road Safety
From Financial Buzz Media
Via GlobeNewswire
4/20 Cannabis Retail Frenzy: Leading Brands Ready For Record Sales Surge - Who Will Lead?
This 4/20 cannabis retailers anticipate record-breaking sales fueled by last year's +130% spike and the fortunate alignment of this year's celebration falling on a Saturday. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Inside The Top Cannabis Business Conference In America: High Expectations For Reform, The Future Of Banking And Taxes
This is an excerpt from Todd Harrison's Cannabis Confidential newsletter, published on April 17. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Chart Of The Week: How Much Have MSO Valuation Multiples Changed In The Last Year And Why?
Most cannabis industry observers realize that valuations and valuations multiples for the major MSOs are up Y/O/Y, spurred by the promise of rescheduling.   
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
52 53 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.